Table 1 Next generation sequencing (NGS) performed on tumor tissue collected from primary tumor biopsy at the initial diagnosis of ampullary adenocarcinoma. The NGS analysis was performed by FoundationOne CDx within the GO40782 clinical trial. Variant allele frequency (VAF) data were made available only for BRCA2 and FANCA genes upon clinical specific request to guide germline assessment in the context of patient’s genetic counseling

From: Multimodal treatment with curative intent in a germline BRCA2 mutant metastatic ampullary adenocarcinoma: a case report